BioStacks

King of Bitters

Herb
KO
Moderate Evidence

About King of Bitters

Andrographis paniculata has moderate clinical evidence for reducing severity and duration of upper respiratory tract infections. A 2017 meta-analysis (33 RCTs, 7,175 patients) found significant improvements in cough and sore throat vs. placebo. Most effective when taken within 36–48 hours of symptom onset. Key active compound is andrographolide, which has poor oral bioavailability — standardized extracts strongly preferred over crude powder. Not recommended for continuous use >12 weeks. Contraindicated in pregnancy.

What King of Bitters supports

  • Reduces severity and duration of cold symptoms (meta-analysis of 33 RCTs)
  • Supports immune function by increasing T cell activity

How much King of Bitters to take

Clinical studies typically use 200–600 mg of King of Bitters. Standardized extract range from RCTs. KalmCold (AP-Bio) clinically tested at 200–400 mg/day. Crude herb powder requires 3,000–6,000 mg/day.

Effective range
200–600 mg

Clinical evidence

Moderate clinical evidence. Meta-analysis of 33 trials (7,175 patients) found significant improvement in cold symptoms

Examine.com
Top Products